Stocks of Fate Therapeutics Inc (NASDAQ:FATE) traded higher last session on Wall Street, up 11.76% to $1.71.
FATE stock price is now 7.26% away from the 50-day moving average and -43.50% away from the 200-day moving average. The market capitalization of the company currently stands at $194.76M.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
On June 17, 2024, Piper Sandler Upgraded its previous ‘Neutral’ rating to ‘Overweight’ on the stock increasing its target price from $4 to quote $6, while ‘Wells Fargo’ rates the stock as ‘Equal Weight’
In other news, Bressi Jerome Charles, insider sold 5,980 shares of the company’s stock on Jan 10 ’25. The stock was sold for $9,269 at an average price of $1.55. Upon completion of the transaction, the insider now directly owns 270,203 shares in the company, valued at $0.46 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Jan 10 ’25, TAHL CINDY sold 5,654 shares of the business’s stock. A total of $8,764 was realized by selling the stock at an average price of $1.55. This leaves the insider owning 336,707 shares of the company worth $0.58 million. A total of 14.07% of the company’s stock is owned by insiders.
During the past 12 months, Fate Therapeutics Inc has had a low of $1.04 and a high of $8.83. As of last week, the company has a debt-to-equity ratio of 0.27, a current ratio of 8.29, and a quick ratio of 8.29.
The net profit margin was -1325.43% and return on equity was -46.59% for FATE. The company reported revenue of $3.07 million for the quarter, compared to $1.94 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 58.13 percent.
